Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Scotland May Now Have Highest Rate of Drug-Related Deaths in the EU

Data published on August 15 by the National Records of Scotland suggest that Scotland now has the highest rate of drug-related deaths of any country in the European Union. Across Scotland, the report says, there were 160 drug-related deaths per one million people in 2016. This compares with an estimated 65.8 per million in England and Wales, and a European average of 20.3 per million.

Published
16 August 2017
From
Talking Drugs
What Trump's National Opioid Emergency Should Look Like

The president should strip away the red tape preventing people from getting methadone or buprenorphine, which are proven to reduce opioid overdose.

Published
15 August 2017
From
Vice
PrEP use in US exceeds 100,000 in Gilead pharmacy survey

An estimated 120,000 people in the US have started Truvada for pre-exposure prophylaxis (PrEP) since 2012, according to the latest findings from a survey of

Published
14 August 2017
By
Liz Highleyman
Mylan launches 3 HIV generics in Canada

Mylan has launched three generics for treating HIV in Canada. Among the three launches is the company’s generic of Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate, 200 mg/300 mg), as well as generics of Atripla (efavirenz, emtricitabine and tenofovir disoproxil fumarate, 600 mg/200 mg/300 mg) and Viread (tenofovir disoproxil, 300 mg).

Published
11 August 2017
From
Drug Store News
Can new 'Smart PrEP Pills' increase adherence for HIV-prevention medication among young people?

Researchers at Cook County Health and Hospitals System are currently recruiting participants in a study to see if, as expected, the smart PrEP pill makes it easier for young people to keep track of their PrEP dosage each day and in the process, significantly reduce their chances of getting HIV/AIDS.

Published
08 August 2017
From
Chicago Daily Herald
Single measures of viral load not effective for assessing HIV suppression status

The percentage of HIV-positive individuals with durable viral suppression may be overestimated when calculated by single measures of viral load, according to findings published in Annals of Internal Medicine.

Published
08 August 2017
From
Healio
In first, healthcare provider to subsidize HIV medication

The decision by Meuhedet to subsidize a generic version of the drug Truvada is set to drive a dramatic drop in prices for HIV medication. Under the new policy, Meuhedet patients were expected to pay NIS 300-500 ($83-$138) for the medication instead of the current cost of some NIS 2,100 ($580).

Published
08 August 2017
From
The Times of Israel
Breakthrough HIV drug: Authorities reconsider decision to block cheap access

People at high risk of HIV could soon get cheap access to a breakthrough preventative drug as federal health authorities revisit their decision to refuse a taxpayer subsidy.

Published
07 August 2017
From
The Sydney Morning Herald
Government could end HIV transmission in Australia with just $32m year

A new plan developed by the Australian Federation of AIDS Organisations says the investment would not only prevent thousands of people contracting the virus but would also eventually deliver $2 billion of savings to the federal government's budget.

Published
07 August 2017
From
The Sydney Morning Herald
Anti-HIV drug may not come under HSE scheme until 2019

A revolutionary anti-HIV drug may not be available under the HSE payment scheme until 2019, a delay that could see up to 800 new infections, health groups have warned.

Published
07 August 2017
From
Irish Times
← First12345...543Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.